The association between small-for-gestational-age (birthweight <10th percentile for gestational age) and neonatal morbidity is well established. Yet, there is a paucity of data on the relationship between suspected small for gestational age (sonographic-estimated fetal weight <10th percentile) at 2 thresholds and subsequent neonatal morbidity. OBJECTIVE: The objective of this study was to determine the relationship between sonographic-estimated fetal weight <5th percentile vs 5e9th percentile and neonatal morbidity. STUDY DESIGN: This retrospective study involved 5 centers and included nonanomalous, singletons with sonographic-estimated fetal weight <10th percentile for gestational age who delivered from 2009e2012. Composite neonatal morbidity included respiratory distress syndrome, proven sepsis, intraventricular hemorrhage grade III or IV, necrotizing enterocolitis, thrombocytopenia, seizures, or death. Odd ratios were adjusted for center, maternal age, race, body mass index at first visit, smoking status, use of alcohol, use of drugs, and neonatal gender. RESULTS: Of 834 women with suspected small-for-gestational-age fetuses, 513 (62%) had sonographic-estimated fetal weight <5th percentile, and 321 (38%) had sonographic-estimated fetal weight of 5e9th percentile for gestational age. At delivery, 81% of women with a suspected small-for-gestational-age fetus had a confirmed small-forgestational-age fetus. In the group with a sonographic-estimated fetal
weight <5th percentile, 59% of neonates had birthweight <5th percentile; in the group with a sonographic-estimated fetal weight 5e9th percentile, 41% had birthweight <5th percentile, and 36% had birthweight at 5e9th percentile. Neonatal intensive care unit admission differed significantly for those fetuses at <5th percentile (29%) compared with those fetuses at 5e9th percentile (15%; P<.001). The composite neonatal morbidity among the sonographic-estimated fetal weight <5th percentile group was higher than the sonographic-estimated fetal weight of 5e9th percentile group (31% vs 13%; adjusted odds ratio, 2.41; 95% confidence interval, 1.53e3.80). Similar findings were noted when the analysis was limited to sonographic-estimated fetal weight within 28 days of delivery (adjusted odds ratio, 2.22; 95% confidence interval, 1.34e3.67). CONCLUSION: Eight of 10 suspected small-for-gestational-age fetuses had birthweight <10th percentile for gestational age; the prediction of actual birthweight was more accurate in the <5th percentile group. Neonates with sonographic-estimated fetal weight of <5th percentile were more likely to be admitted to the neonatal intensive care unit and have complications than were those neonates with sonographic-estimated fetal weight of 5e9th percentile.
Key words: small for gestational age, sonographic-estimated fetal weight S uspected small for gestational age (SGA) has been defined variably as sonographic-estimated fetal weight (SEFW) <10th percentile or <5th percentile for gestational age (GA), as abdominal circumference <10th or <5th percentile for GA, as flattening of the growth curve, or as abnormal of umbilical artery Doppler; the categorization of growth has used population, customized, or ethnic based nomograms. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] SGA at birth has been defined as birthweight at <25th, <15th, <10th, <5th, or <3rd percentile for GA. [17] [18] [19] [20] [21] [22] [23] [24] Notwithstanding the various thresholds used thus far, American College of Obstetricians and Gynecologists and Society of Maternal-Fetal Medicine characterize suspected SGA as SEFW <10th percentile for GA and SGA as a birthweight <10th percentile for GA. 25, 26 Pregnancies with suspected SGA are at increased risk of fetal death, medically indicated preterm birth, and cesarean delivery for nonreassuring fetal heart rate tracing. 4, 7, 9, 16, 27, 28 SGA newborns are at increased risk of respiratory distress, intubation at term, proven sepsis, necrotizing enterocolitis, neonatal seizure, neonatal, and infant death. [20] [21] [22] [23] [29] [30] [31] [32] [33] [34] [35] Moreover, they are also more likely to have neurologic sequelae, autism, and, later in life, adult-onset noncommunicable diseases such as hypertension and diabetes mellitus. [36] [37] [38] [39] [40] Despite the known association between SGA and poor outcomes, 4, 9, 16, [20] [21] [22] [23] [27] [28] [29] [30] [31] [32] [33] [34] [35] there are 3 important issues. First, that the threshold of SEFW of suboptimal growth is associated with adverse neonatal outcomes is a subject of debate. Some recommend suspected SGA if SEFW is <10th percentile. McIntire et al, 23 however, reported that neonatal morbidity became significant only when neonates were <3rd [41] [42] [43] it is assumed that the morbidity and mortality rates that are associated with sonographic and actual birthweight are of similar magnitude. [2] [3] [4] [5] [6] 8, 25, 26, 44 Third, unlike nomograms of birthweight for GA, 45, 46 most of the regression equations that estimate fetal weight do not provide value to categorize them as <3rd percentile 47, 48 ; hence, this threshold is difficult to use in daily clinical practice.
An important study that examined SEFW with perinatal morbidity and death was reported in Ireland (Prospective Observational Trial to Optimize Pediatric Health in Intrauterine Growth Restriction [PORTO] study). 6 In >1100 singletons with SEFW <10th percentile for GA, Unterscheider et al 6 found that the adverse neonatal outcomes were related to SEFW <3rd percentile and abnormal umbilical artery Doppler velocimetry.
These investigators cautioned that these results may not be generalizable to other countries with different demographics and obstetrics practices. 6 Thus, there is a need to determine the neonatal outcomes among those with SEFW <10th percentile and to determine whether it differs among those with estimated <5th vs 5e9th percentile for GA in a US population.
The primary objective of this study was to determine whether the composite neonatal morbidity was significantly different in neonates with SEFW <5th vs 5e9th percentile for GA in an US population. The secondary objective of this study was to compare the frequency composite neonatal morbidity with SEFW <5th vs 5e9th percentile, if the last ultrasound for SEFW was performed within 28 days before delivery. 41, 49 
Materials and Methods
This was a retrospective cohort study that used the Fellows and Residents Research Network that is affiliated with Central Association of Obstetricians and Gynecologists. Five tertiary academic centers participated in this multicenter study: Eastern Virginia Medical School, University of Cincinnati, University of Missouri Kansas City, Medical University of South Carolina, and University of Mississippi. Each participating center obtained approval from their respective institutional review boards. At each of the centers, residents in an obstetricsgynecology program or a maternal-fetal medicine fellow identified the pregnancies with SEFW <10th percentile and culled the data from the prenatal visits, sonographic examinations, peripartum course, and neonatal outcomes. The cases were identified by querying the ultrasound database and labor and delivery log books. Only those patients with a complete record of delivery at 1 of the participating institutions were included in the study.
With the use of ultrasound database and labor and delivery log books, all pregnancies with the diagnoses of SGA were identified at the 5 centers. The inclusion criteria for the study were singleton gestation, no known anomalies (no abnormal karyotype and/or major anatomic deformity), early ultrasound examinations at <22 weeks for confirmation of estimated due date, SEFW <10th percentile for GA at any time between 24 weeks and delivery, and live birth, which was defined by an Apgar score of at least 1 at 1 minute of life. We excluded women with multiple gestation, SEFW <10th percentile at <22 weeks gestation, late prenatal care (first ultrasound scan after 22 weeks gestation), fetuses with known anomalies, stillbirths, delivery at <24 weeks gestation, and those who were transferred for delivery.
All women who met inclusion criteria had fetuses suspected to have SGA between January 1, 2009, and December 31, 2012, at participating centers were included in the study. At each center, the 4 biometric parameters (biparietal diameter, head and abdominal circumference, and femur length) that were used to derive the estimated fetal weight were measured according to the American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin on ultrasonography in pregnancy. 43 Additionally at all centers, suspected SGA was defined as any SEFW at !24 weeks gestation that was <10th percentile for GA, with the use of Hadlock's regression equation to estimate fetal weight. 47 A priori, we choose to compare SEFW <5th vs 5e9th percentile for GA because these thresholds were noted in the ultrasound reports at all 5 centers and because determination of whether the fetus was or >3rd percentile was not available to clinicians at the centers. The first ultrasound scan that detected growth restriction was used to categorize the cohorts into the 2 groups. At birth, the Alexander's nomogram was used to categorize newborn infants as <5th, 5e9th, or !10th percentile. 45 Gestational hypertension and mild and severe preeclampsia were defined according to ACOG Practice Bulletin recommendations at the time of diagnosis. 50 The composite maternal morbidity was defined as a peripartum course that was complicated by any of the following events: intubation, admission to intensive care unit, blood transfusion, pulmonary edema, amniotic fluid embolism, or cesarean hysterectomy. Composite neonatal morbidity was defined as the presence of any of the following symptom: respiratory distress syndrome (RDS), proven sepsis, intraventricular hemorrhage grade III or IV, necrotizing enterocolitis, thrombocytopenia, seizures, and death. RDS was defined as a need for the use of a ventilator in the first 24 hours of life. Sepsis was diagnosed when a positive blood culture was documented. Intraventricular hemorrhage was classified according to Papile's criteria. 51 Necrotizing enterocolitis was diagnosed by neonatologists when >1 clinical sign and at least 1 radiographic finding was present. Clinical signs for necrotizing enterocolitis included bilious gastric aspirate or emesis, fecal blood (occult or gross), and abdominal distention. Radiographic findings for necrotizing enterocolitis included pneumatosis intestinalis, hepatobiliary gas, and pneumoperitoneum. Thrombocytopenia was diagnosed when the platelet count was 5th percentile at a specific GA. 52, 53 Neonatal death was defined as death within 28 days after birth.
Our sample size calculation, based on the previous finding of composite ajog.org OBSTETRICS Original Research neonatal morbidity of 30% among SGA infants, 54 indicated that 300 patients were needed in each group to show 10% difference in composite neonatal morbidity (from 30e20%) with a power of 80% and a 2-tailed alpha of .05. Data are presented as mean AE standard deviation or nominal values and were analyzed with the use of the Student t test for continuous variables and chi-square or Fisher's exact test for categoric variables, respectively. A log-binominal regression model was used to estimate odds ratio and 95% confidence interval. An adjustment for the following 8 confounders was performed: center, maternal age, race, body mass index at first visit, smoking status, self-reported use of alcohol or drugs, and neonatal gender. We adjusted for body mass index because it is associated with identification and peripartum outcomes with fetal abnormal growth. 55, 56 Statistical analyses were performed with SAS software (version 9.3; SAS Institute, Cary, NC).
Results
Of 834 patients who met inclusion criteria, 513 (62%) had SEFW <5th percentile, and 321 (38%) had SEFW at 5e9th percentile. The frequency of the estimated fetal weight at <5th vs 5e9th percentile did not differ among the centers (P¼.343). Maternal demographics and clinical characteristics are presented in Table 1 . The distribution by maternal age, nulliparity, body mass index at the first visit, ethnicity, and use of alcohol and tobacco were similar between the 2 groups. There was no difference in clinical and demographic characteristics between the 2 groups, except for drug use during pregnancy: 9.4% in <5th percentile group vs 5.3% in 5e9th percentile group.
There were no differences in the past medical or obstetric history (Table 2) . Both groups reported similar rates of previous preterm deliveries and the same incidence of SGA in previous pregnancies. The maternal antepartum complications for the 2 groups are noted in Table 3 . Women with SEFW <5th percentile had a higher frequency of mild and severe preeclampsia compared with the 5e9th percentile group. The GA at the diagnosis of severe preeclampsia was similar for both groups: 31.1 AE 3.7 weeks gestation in those with fetuses estimated at <5th percentile vs 31.7 AE 3.9 weeks gestation in those with fetuses estimated at 5e9th (P>.05). GA at diagnosis of cases with SEFW <5th percentile was approximately 2 weeks earlier than suspected SGA 5e9th percentile (30.5 AE 5.6 Original Research OBSTETRICS ajog.org vs 32.5 AE 4.6 weeks gestation) and was more likely to persist at the last ultrasound examination before delivery (97% vs 80%, respectively; P<.0001).
The mean GAs at delivery were similar (35.7 AE 3.6 vs 35.6 AE 3.6 weeks gestation), although the patients in the SEFW <5th percentile group were more likely to deliver at <32 weeks gestation (20% vs 9%, respectively; Table 4 ). The route of delivery differed between the 2 groups; the majority of women with fetuses with SEFW <5th percentile had a cesarean delivery. The composite maternal morbidity rate was similar for the 2 groups (Table 4 ). The mean time interval between the last ultrasound examination and delivery did not differ between groups (8.0 AE 12.1 days in the <5th percentile group and 8.4 AE 8.9 days in the 5e9th percentile group). Table 5 provides a summary of the neonatal outcomes. Among deliveries at <34 weeks gestation, antenatal corticosteroids were administrated in >90% cases. Most newborn infants (59%) with SEFW <5th percentile had an actual birthweight of <5th percentile for GA; in contrast, approximately 40% of newborn infants with SEFW at 5e9th percentile had an actual birthweight of <5th percentile for GA. Newborn infants with actual weight of >10th percentile were more common among pregnancies with SEFW 5e9th percentile vs those infants with <5th percentile (23% vs 16%; P¼.011). The frequency of Apgar score <7 at 5 minutes and umbilical arterial pH <7.00 were similar for the 2 groups. Admission to the neonatal intensive care unit differed significantly (29% vs 15%; P<.001), but the average length of neonatal intensive care unit stay was comparable ( Table 5) .
The composite neonatal morbidity for the 2 groups is provided in Table 6 . Compared with those infants with SEFW at 5e9th percentile, the composite neonatal morbidity rate was significantly higher for those with estimate <5th percentile for GA. At each center, the frequency of composite neonatal morbidity for those with SEFW <5th percentile vs those at 5e9th percentile was similar (P¼.185). In both groups, the most common morbidity was RDS, which was the only 1 significantly different between the groups. Among women with SEFW within 28 days of delivery, the composite neonatal morbidity rate differed significantly (Table 7) for those with SEFW <5th percentile vs 5e9th percentile for GA; the most common morbidity was RDS.
There were 19 deaths among the cohort; 4 of the deaths occurred at >28 days of life. The median GA for the diagnosis of suspected SGA among the 15 neonatal deaths was 24.6 weeks gestation (range, 20.6e31.0 weeks gestation), and the median GA for delivery was 27.5 weeks gestation (range, 24.6e31.1 weeks gestation). Overall, the neonatal mortality rate was 18.0 per 1000 live births (15/834). For newborn infants with SEFW <5th percentile for GA, the mortality rate within 28 days was 
Comments

Principal findings of this study
Compared with singleton pregnancies with SEFW at 5e9th percentile, those at <5th percentile had significantly higher composite neonatal morbidity rates. The adjusted odds of morbidity was >2-fold higher among those pregnancies with SEFW <5th percentile, regardless of whether the suspected SGA was noted in early third trimester examination or on the ultrasound examination within 28 days of the delivery (Tables 6 and 7) . This finding, although intuitive, differs from most publications on suboptimal fetal growth that have linked birthweight at <10th percentile with adverse outcomes. Of all patients who at met inclusion criteria, almost two-thirds of the group (62%) had SEFW <5th percentile, and one-third of the group (38%) had SEFW 5e9th percentile. Because the uneven distribution of our study subject between groups is a little surprising, we hypothesize that it is due to the fact that suspected SGA is more likely to be detected by screening ultrasound scans than SEFW 5e9th percentile. Another possible explanation is that patients with more SEFW <5th percentile are more likely to be referred to tertiary centers where our study was performed.
The observed discrepancy in detection of low birthweight between 2 groups is consistent with previous data published by Chauhan et al 54 that indicated the poor detection rate of growth restriction by prenatal ultrasound scanning. Our findings suggest that the more severe SGA the better correlation with the actual birthweight.
Our study shows that the composite neonatal morbidity rate is almost 1.4-fold higher when the SEFW is <5th percentile than those at 5e9th percentile (32% vs 13%) and differs significantly after adjustment for 8 confounders (Table 6 ). The 8 confounders we adjusted for did not include GA. Although adjustment for GA may be appealing clinically, we believe that it introduces bias in the reported associations because it is in the causal pathway between the exposure (indication for delivery) and the outcomes (neonatal morbidity and death). 53 Despite the fact that >90% of newborn infants who were (Table 5) , RDS was the common morbidity among the 2 groups (Table 6 ). The association between growth restriction and respiratory morbidity has been reported, 24, 29, 33, 73 with the putative cause being reduced or impaired surfactant release or diminished response to glucocorticoids. 74 An elevated risk of RDS in the 5e9th percentile group (13% of neonates) may be related to the fact that 33% of neonates who form the 5e9% percentile group have been born prematurely, at <37 weeks gestation. Further prospective studies with a control group of normally grown fetuses are needed to clarify what neonates from the 5e9th percentile group are at risk of the development of RDS and should be delivered at the tertiary centers. We speculate that pregnancies at <37 weeks gestation still may be referred to higher level of care hospitals, although those at term may be safely delivered in local hospitals.
Although the most common morbidity was RDS, the high neonatal mortality rate among nonanomalous suspected SGA was notable. Overall, the corrected neonatal mortality rate among fetuses with SEFW at <10th percentile was 18.0 per 1000 live births: 25.3 if the SEFW was <5th percentile, and 6.2 if it was 5e9th percentile. Such a high mortality rate within 28 days of birth among suspected SGA is remarkable, considering that, in the United States, the neonatal mortality rate is approximately 4.0 per 1000 live births, which includes congenital malformations, which the leading cause of death among newborn infants. 75 A comparison of neonatal mortality rates reported among fetuses with SEFW <10th percentile is notable for wide variation: 0 per 1000 live births was reported in the randomized trial by Boers et al 69 to 59.6 by the GRIT trial. 70 The reasons for disparity in neonatal mortality rates among various reports are the type of studies (retrospective vs prospective, single vs multiple centers, observational vs randomized trial), sample size, ethnicity, GA at recruitment, 
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proportion of cohorts with absent or reverse umbilical diastolic flow, and management schema once SGA is suspected.
2-4,6,9,18,25,27,28,57-59,61,69-72 A large prospective observational study is warranted to assess accurately the neonatal morbidity that is associated with suspected SGA and to identify the modifiable risk factors.
In addition to the composite neonatal morbidity, our study provided nuanced information on SEFW at <10th percentile for GA that can be used to counsel women and to plan randomized trials. For fetuses who are diagnosed as being growth restricted, 2 of 3 fetuses had SEFW <5th percentile. Approximately one-third of pregnancies with suspected SGA have medical complications. The frequency of SEFW that is >10th percentile in subsequent sonographic examinations is significantly higher when the SEFW is at 5e9th percentile rather than <5th percentile ( Table 2 ). The route of delivery, especially cesarean for nonreassuring fetal heart rate tracing, differs on the threshold that is used to define suspected SGA. The composite maternal morbidity, however, is similar for those with SEFW <5th percentile vs 5e9th percentile (Table 4) . Among women with suspected SGA, 81% (677/ 834) will deliver a newborn infant with actual weight <10th percentile or SGA. For fetuses with SEFW at 5e9th percentile, approximately 40% will have an actual birthweight at <5th percentile, which is the group at risk for composite neonatal morbidity (Table 5) .
We compared our study with the PORTO 6 study, because they were both recently performed multicenter studies on SEFW <10th percentile and neonatal outcomes. The design of the PORTO study differs from ours in that it is prospective with prespecified aims, trained sonographers at 7 academic centers, and consistent management schema. 6 Despite these differences, we believe that our study is clinically useful for the population and that pregnancy management differs between Ireland and United States. These differences are best exemplified by the neonatal mortality rates with SEFW at <10th percentile in the PORTO study (2.7/1000 live births) vs our study (18.0/1000 live births). 6 As in our study, in the PORTO trial, mortality rates among those with SEFW <5th percentile were higher than those with SEFW 5e9th percentile: 8 vs 2.7 per 1000 births. We agree with Unterscheider et al 6 that this discrepancy in neonatal mortality rate may be explained, in part, by the variation in ethnicity, the rate of obesity, the prevalence of medical and obstetric complications, the ante-and intrapartum management, and the GA at delivery.
Limitations and strengths
Limitations of our retrospective study should be acknowledged, which includes selection bias. It is notable that several publications on suspected SGA [2] [3] [4] 9, 27, 61 from the United States and on SGA are retrospective. 7,10,11,15,17,20,22-24,28-35,38-40, 53-56,62-68 Because this study was designed to assess the peripartum outcomes with suspected SGA in daily practice in the United States, there was no prespecified training of the sonographers. Theoretically, we should have equal proportion of fetuses that had SEFW at <5th and 5e9th percentile for GA. The fact that our ratio of fetuses with estimated weight at <5th percentile Original Research OBSTETRICS ajog.org was 1.5 times more common than at 5e9th percentile for GA may indicate that women who are treated at tertiary centers have more comorbidity and "severe" SGA than those in the general obstetric population or that "severe" SGA are more likely to be detected than SGA that approaches the 10th percentile. It is notable that, in the prospective study 6 of 1116 with SEFW <10th percentile in Ireland, 94% (n¼1047) were <5th percentile for GA. Thus, a majority of suspected SGA that is detected at academic centers is <5%, whether it be in the United States or in Ireland. 6 Notwithstanding the disproportionate fraction, providing the neonatal morbidity information separately for the 2 groups permits clinicians to use the data for counseling and management. Because all of the SEFW and deliveries occurred in teaching centers, the neonatal outcomes may differ in community hospitals. The treatment of the women with suspected SGA was not prespecified; however, considering that all centers are tertiary hospitals with graduate medical education in obstetrics-gynecology, the practice is assumed to be congruent with ACOG and Society of Maternal Fetal Medicine guidelines. 1, 16, 38 In the current report, we did not segregate the outcomes based on the results of Doppler imaging; however, for our first report, we wanted to focus just on the link with SEFW and neonatal outcomes. We also did not collect data on serial sonographic examinations and thus cannot comment on growth velocity and adverse outcomes. 40, 76 We did not collect any data 25, 26, 44 we defined growth restriction as <10th percentile for GA and did not account for growth potential, which some investigators have used to characterize growth restriction. 77, 78 We excluded stillbirths from our study and focused on neonatal outcomes. Although the stillbirth rate in the suspected SGA population does provide valuable information, we do not have this information because the retrospective design of the study prevented us from determining the time interval from death to delivery. A priori, we did not have an algorithm that estimated the percentile growth at the time of death, 79 and most women with fetal death delivered at the hospital where they were referred from rather than at the academic centers where the data were collected. Higher incidence of severe preeclampsia in patients with SEFW at <5th percentile may also be a subject of separate subanalysis of the current study and should be included in prospective study to better explain this finding. We did not use the results of the INTERGROWTH-21st study that prospectively collected data on fetal growth in 8 countries. Our reason for not using the data from the multicountry trial was that these measurements were not available for use at the centers that participated. 15, 80, 81 Last, we used the Hadlock et al 47 equation to estimate fetal weight, which has been criticized aptly for being a descriptive reference chart derived decades ago that was based on a small sample size in Texas. 82 Yet, it is remarkable that the suspected SGA did identify newborn infants at risk of morbidity.
The strengths of the study should be mentioned. This is 1 of the few studies on the topic with sufficient power and a prespecified hypothesis that involves multiple centers with generalizable results. Our data reports on pregnancy and neonatal outcomes based on SEFW and not birthweight.
In summary, compared with an estimate of 5e9th percentile, SEFW at <5th percentile is associated with a higher frequency of composite neonatal morbidity. Our data provide clinically useful information to counsel women, albeit in academic centers, with an SEFW <5th vs 5e9th percentile for GA and is an impetus to design an interventional trial to mitigate morbidity with suspected SGA. 83, 84 n
